Mitchell R S, Dake M D, Sembra C P, Fogarty T J, Zarins C K, Liddel R P, Miller D C
Department of Radiology, Stanford University School of Medicine, CA 94305-5247, USA.
J Thorac Cardiovasc Surg. 1996 May;111(5):1054-62. doi: 10.1016/s0022-5223(96)70382-3.
Conventional repair of aneurysms of the descending thoracic aorta entails thoracotomy and graft interposition. For elderly patients and those with previous operations, obesity, respiratory insufficiency, or other comorbidities, such a procedure entails significant mortality and morbidity. Transluminal stent-graft placement offers an alternative approach with potentially less morbidity and quicker recovery; however, the effectiveness and durability of stent-grafts remain uncertain.
Since July 1992, thoracic aortic stent-grafts have been placed in 44 patients with a variety of pathologic conditions. Each graft was individually constructed from self- expanding, stainless-steel Z stents covered with a woven Dacron polyester fabric graft. Craft dimensions were determined from spiral computed tomographic scans. All implants were performed in the operating theater under fluoroscopic and transesophageal echocardiographic guidance. Follow-up was by computed tomography and contrast angiography in all cases.
There were 36 men and 8 women. Mean age was 66 years (range 35 to 88 years). Mean aneurysmal diameter was 6.3 cm (range 4.0 to 9.4 cm). Etiologies included 23 degenerative aneurysms, four posttraumatic aneurysms, four pseudoaneurysms, and one chronic aortic dissection.
There were three early deaths (<30 days) and two late deaths. One early death resulted from graft failure. There were two instances of paraparesis or paraplegia, with one associated early death. A single stent was deployed in 27 patients, two stents were required in 14 patients, and three stents were required in three patients. In 23 patients, vascular access was attained through the femoral artery; abdominal aortic access, either native or graft, was necessary in the remaining 21 patients. Twelve grafts were placed in conjunction with open abdominal aortic surgical procedures. Mean follow-up (98% complete) was 12.6 months (range 1 to 34 months). One late death occurred from aneurysmal expansion and rupture in a patient with a persistent midgraft leak. The second late death may have resulted from aneurysmal rupture. Immediate thrombosis was achieved in 36 patients, and late thrombosis was achieved in three others. Failure to achieve complete aneurysmal thrombosis occurred in five patients, however, and one individual (previously noted) died of aneurysmal expansion and rupture; the remaining four are being carefully monitored. Only one patient has required conversion of the stent to an open procedure; a contained rupture of the false lumen of a chronic dissection eventually necessitated total descending thoracic aortic exclusion.
These early results support the hypothesis that endovascular stent-graft placement may be a safe and durable treatment for selected patients with aneurysmal disease of the descending thoracic aorta. Large introducer size (26F outer diameter) and relatively limited angulation capability, as well as imprecise deployment techniques, currently limit its applicability. Distal embolization and stent migration have not been observed. Failure to achieve complete aneurysmal thrombosis may allow continued aneurysmal expansion and rupture. Further follow-up is clearly necessary to evaluate the true long-term effectiveness of this procedure.
传统的胸降主动脉瘤修复术需要开胸并植入移植物。对于老年患者以及曾接受过手术、肥胖、呼吸功能不全或有其他合并症的患者,这样的手术会带来较高的死亡率和发病率。经腔血管内支架移植物置入提供了一种替代方法,其潜在发病率较低且恢复较快;然而,支架移植物的有效性和耐久性仍不确定。
自1992年7月以来,已为44例患有各种病理状况的患者置入胸主动脉支架移植物。每个移植物均由自膨式不锈钢Z形支架和覆盖有编织涤纶织物移植物单独构建而成。移植物尺寸根据螺旋计算机断层扫描确定。所有植入操作均在手术室的荧光镜和经食管超声心动图引导下进行。所有病例均通过计算机断层扫描和造影血管造影进行随访。
男性36例,女性8例。平均年龄66岁(范围35至88岁)。平均动脉瘤直径为6.3厘米(范围4.0至9.4厘米)。病因包括23例退行性动脉瘤、4例创伤后动脉瘤、4例假性动脉瘤和1例慢性主动脉夹层。
有3例早期死亡(<30天)和2例晚期死亡。1例早期死亡是由于移植物失败。有2例发生截瘫或偏瘫,其中1例伴有早期死亡。27例患者置入单个支架,14例患者需要置入2个支架,3例患者需要置入3个支架。23例患者通过股动脉获得血管通路;其余21例患者需要通过腹主动脉获得血管通路,无论是天然的还是人工血管。12例移植物与开放性腹主动脉手术联合置入。平均随访时间(98%完整)为12.6个月(范围1至34个月)。1例晚期死亡发生在1例移植物中部持续渗漏的患者,因动脉瘤扩张破裂。第2例晚期死亡可能是动脉瘤破裂所致。36例患者实现了即刻血栓形成,另外3例实现了晚期血栓形成。然而,5例患者未能实现完全动脉瘤血栓形成,1例患者(前文提及)死于动脉瘤扩张破裂;其余4例正在密切监测。只有1例患者需要将支架转换为开放手术;1例慢性夹层假腔的局限性破裂最终需要完全胸降主动脉切除术。
这些早期结果支持这样的假设,即血管内支架移植物置入对于胸降主动脉瘤疾病的特定患者可能是一种安全且持久的治疗方法。目前,较大的导入器尺寸(外径26F)、相对有限的成角能力以及不精确的置入技术限制了其适用性。未观察到远端栓塞和支架移位。未能实现完全动脉瘤血栓形成可能会导致动脉瘤持续扩张和破裂。显然需要进一步随访以评估该手术的真正长期有效性。